RES significantly increased the accumulation of the established BCRP substrates, mitoxantrone (MX) and BODIPY FL prazosin, in BCRP-overexpressing, MX-resistant MCF/MR cells, derived from MCF-7 breast cancer cells but not in wild-type cells [38]. This evidence concerns the gene ABCG2 and breast carcinoma.